Clinical Trials Logo

Filter by:
NCT ID: NCT05973032 Completed - Clinical trials for Acute Lymphoblastic Leukemia, Pediatric

MRD Detection by NGS in Pediatric B-ALL

Start date: November 1, 2018
Phase:
Study type: Observational

This retrospective analysis aims to investigate pediatric patients with B-cell acute lymphoblastic leukemia who were detected for minimal residual disease (MRD) using next-generation sequencing (NGS). The study will utilize second-generation sequencing technology to analyze the rearrangement of the immunoglobulin heavy chain (IGH), immunoglobulin kappa light chain (IGK), and immunoglobulin lambda light chain (IGL) genes in these patients. Patients will be stratified based on NGS-MRD levels, and the relationship between NGS-MRD and Event-Free Survival (EFS) will be evaluated.

NCT ID: NCT05968365 Completed - the Blind Clinical Trials

Evaluate the Safety and Effectiveness of Electronic Vision-aid Device

Start date: February 1, 2021
Phase: N/A
Study type: Interventional

To evaluate the safety and effectiveness of electronic Vision-aid Device in walking and obstacle recognition for visually blind people

NCT ID: NCT05968235 Completed - Vitiligo Clinical Trials

Correlation of Glucose and Lipid Metabolism Levels With Vitiligo

Start date: February 1, 2020
Phase:
Study type: Observational [Patient Registry]

The goal of this observational study is to compare serum glucose and lipid metabolism levels between health volunteers and vitiligo patients. The main question it aims to answer is whether vitiligo is related to glucose and lipid metabolism disorders. Participants will complete a vitiligo questionnaire and test serum levels of indicators related to glucose and lipid metabolism. Researchers will compare vitiligo patients with healthy volunteers to see if there is a correlation between vitiligo and disorders of glucose and lipid metabolism.

NCT ID: NCT05967702 Completed - Myopia Clinical Trials

A 3-year Cross-sectional Assessment of the Tianjin Child and Adolescent Large-scale Eye Study

Start date: July 1, 2019
Phase:
Study type: Observational

This is a school-based, cross-sectional study to assess the incidence and prevalence, risk factors of myopia among schoolchildren in both eye-use environment, eye-use habits, lifestyle, and family and subjective factors before and during COVID-19. Large population and representative study subjects. Environmental exposure and daily within and out-of-school activities will be evaluated in a random subgroup.

NCT ID: NCT05962125 Completed - Clinical trials for Postoperative Pulmonary Complications

The Role of Periodic Alveolar Recruitment Maneuvers in Intraoperative Protective Ventilation

REMAIN-2
Start date: August 21, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to compare three open-lung strategies on respiratory function and lung injury in protective ventilation for laparoscopic anterior resection. It aims to answer whether a periodic alveolar recruitment maneuvers (PARM) strategy alone was an appropriate open-lung strategy in intraoperative protective ventilation. Patients were randomly assigned (1:1:1) to receive one of three open-lung strategies in protective ventilation: PARM alone (alveolar recruitment maneuvers [ARM] repeated every 30 min), positive end-expiratory pressure (PEEP) alone (a PEEP of 6 to 8 cm H2O), or a combination of PEEP and PARM (a PEEP of 6 to 8 cm H2O combined with ARM repeated every 30 min). The primary outcome is the mechanical power before the end of intraoperative mechanical ventilation. Secondary outcomes included the accumulative intraoperative mechanical power, an arterial partial pressure of oxygen (PaO2) / inhaled oxygen concentration (FiO2) ratio (P/F ratio) before the end of intraoperative mechanical ventilation, the rates of respiratory failure at post-anesthesia care unit (PACU) and three postoperative days, the concentration of soluble advanced glycation end products receptor (sRAGE) and Clara cell protein 16 (CC16) at the end of surgery, postoperative pulmonary complications score, postoperative hospitalization days and so on.

NCT ID: NCT05961462 Completed - Long COVID-19 Clinical Trials

Effects of Exercise Training on Patients With Long COVID-19

Start date: January 10, 2023
Phase: N/A
Study type: Interventional

Effects of Exercise training on Patients With Long COVID-19, is a single-center, randomized, controlled trial designed to evaluate the effects of 4- week aerobic exercise administered to patients with long COVID-19 symptoms. The main outcome is cardiopulmonary fitness and long COVID-19 symptom improvement. Quality of life, depression, anxiety, insomnia status and perceived stress will also be assessed before and after the exercise program.

NCT ID: NCT05960942 Completed - Clinical trials for Autism Spectrum Disorder

Application of Esketamine in Anesthesia of Autism Children

Start date: August 1, 2023
Phase: N/A
Study type: Interventional

Autism Spectrum Disorder (ASD) is a group of serious neurodevelopmental disorders. Autistic children appear with significant frequency for medical services, lots of which requiring procedural sedation or anaesthesia. Autistic children have often been described as difficult to sedate or anesthetize due to a variety of ASD symptoms. It is a challenging task to provide safe and effective sedation during the procedure of colonic TET for FMT in autism children. The investigators intend to explore an optimum anesthetic regimen for autism children undergoing endoscopic procedures.

NCT ID: NCT05960032 Completed - Healthy Clinical Trials

A Study to Learn About the Study Medicine Called Zavegepant in Healthy Chinese Adult Participants

Start date: October 23, 2023
Phase: Phase 1
Study type: Interventional

The purpose of this study is to learn about: - how Zavegepant is changed and removed from the body after taken. - safety of Zavegepant. - the extent to which side effects can be tolerated after taking Zavegepant for the possible short-term treatment of migraine. This study is seeking participants who: - are healthy Chinese adults and includes participants who are between 18 to 55 years old. - have body mass index (BMI) of 18 to 30 kg/m^2. - have a total body weight of: - equal to or more than 50 kilograms (110 pounds) for males. - equal to or more than 45 kilograms (99 pounds) for females. - are non-smoker (no use of tobacco or nicotine products). All participants in this study will receive Zavegepant by nose, once at the study clinic. The experiences of the participants receiving the study medicine will be looked at. This will help see if the study medicine is safe. Participants will take part in this study for around 9 weeks. During this time, participants will have 2 study visits at the study clinic and 1 contact over the phone.

NCT ID: NCT05959187 Completed - Depressive Disorder Clinical Trials

A Single-center Randomized Controlled Study on the Effect of Pharmacogenomics Trial on Clinical Efficacy in Patients With Depression

Start date: July 15, 2020
Phase: N/A
Study type: Interventional

The purpose of this clinical trial is to explore the efficacy of drug therapy under the guidance of pharmacogenomics test in the treatment of patients with depression. The main questions to be answered in this study are: 1. Whether the drug treatment regimen under the guidance of pharmacogenomics test is beneficial to the rehabilitation of patients with depression. 2. Pharmacogenomics tests whether it can reduce adverse drug reactions during treatment, and be evaluated by the scale before and after treatment. The researchers will compare the pharmacogenomics test group with the healthy control group to see the effect of drug therapy under the guidance of pharmacogenomics test on the efficacy of patients with depression.

NCT ID: NCT05958576 Completed - Clinical trials for Non-obstructive Azoospermia

Effect of Age on Sperm Recovery of Microdissection Testicular Sperm Extraction in Nonobstructive Azoospermia Patients

Start date: March 1, 2012
Phase:
Study type: Observational

Males with non-obstructive azoospermia (NOA) have an opportunity to obtain sperm by treatment with microdissection testicular sperm extraction (mTESE), gold-standard surgical technique for them. The overall sperm retrieval rate (SRR) of mTESE in NOA patients is about 50%, but the predictive factors of SRR remain were understudied, especially the effect of age. The purpose of this study was to explore the factors influencing the SRR of mTESE in NOA patients with different etiologies. Methods: This observational study recruit NOA patients treated with their first mTESE. The stratified research was used to investigate SRR by dividing patients into seven groups based on etiology. The primary outcome was SRR. Multivariable logistic regression was used to analyze the factors influencing SRR.